Submit to JCM Review for JCM Propose a Special Issue

Journal Menu

Journal Browser

New Insights and Future Directions in Cardiac Electrophysiology Techniques

Special Issue Editors
Special Issue Information
Keywords
Published Papers

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Cardiology".

Deadline for manuscript submissions: closed (31 January 2022) | Viewed by 21229

Share This Special Issue

Special Issue Editors

Prof. Dr. Christian Sohns

E-Mail Website
Guest Editor

Clinic for Electrophysiology, Herz- und Diabeteszentrum NRW, Ruhr-Universität Bochum, 32545 Bad Oeynhausen, Germany
Interests: cardiac arrhythmias; catheter ablation; device therapy; heart failure; magnetic resonance imaging
Special Issues, Collections and Topics in MDPI journals

Dr. Philipp Sommer

E-Mail Website
Guest Editor

Special Issue Information

Dear Colleagues,

Several observations have led to individual mechanistic insights in arrhythmia management and its associated cardiac remodeling, which emphasize the need for personalized paths in arrhythmia management. Catheter ablation has been proven to be superior to antiarrhythmic drug therapy in maintaining sinus rhythm in the majority of arrhythmias, but despite improvements in ablation technology, imaging modalities, and ablation techniques, arrhythmia recurrence after ablation has not been completely overcome. The underlying mechanisms behind individual arrhythmia substrates and recurrences are diverse, and understanding them can be challenging.

Novel technologies have been introduced, and new approaches for the diagnosis and treatment of arrhythmias have been proposed, enabling a more specific patient management. The progress also concerns preprocedural planning, patient selection, modified endpoints, continuous monitoring, treatment, as well as a revised classification of arrhythmogenic disorders. In addition, imaging has achieved a central role for arrythmia management and therapy. More and more we need individual paths in arrhythmia management.

This Special Issue of Journal of Clinical Medicine, “New Insights and Future Directions in Cardiac Electrophysiology Techniques”, will focus on recent improvements, developments, and findings in the field of diagnostics and treatment of cardiac arrhythmias. Furthermore, manuscripts summarizing the current state of knowledge, original articles on arrhythmias related to specific diseases or disciplines, and those highlighting potential gaps in our understanding are also welcome.

Dr. Christian Sohns
Dr. Philipp Sommer
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

cardiac arrhythmias
atrial fibrillation
ventricular arrhythmias
arrhythmia burden
continuous monitoring
heart failure
implantable cardioverter-defibrillators
cardiac resynchronization therapy
catheter ablation
arrhythmogenic disorders
channelopathies
cardiomyopathies

Published Papers (10 papers)

Download All Papers

Order results

Result details

Show export options Show export options

Select all

Export citation of selected articles as:

Research

Jump to: Review

10 pages, 2014 KiB

Open AccessArticle

Initial Experience with Left Bundle Branch Area Pacing with Conventional Stylet-Driven Extendable Screw-In Leads and New Pre-Shaped Delivery Sheaths

by Kyeongmin Byeon, Hye Ree Kim, Seung-Jung Park, Young Jun Park, Ji-Hoon Choi, Ju Youn Kim, Kyoung-Min Park, Young Keun On and June Soo Kim

J. Clin. Med. 2022, 11(9), 2483; https://doi.org/10.3390/jcm11092483 - 28 Apr 2022

Cited by 6 | Viewed by 1838

Abstract

Until recently, left bundle branch area pacing (LBBAp) has mostly been performed using lumen-less fixed screw leads. There are limited data on LBBAp with conventional style-driven extendable screw-in (SDES) leads, particularly data performed by operators with no previous experience with LBBAp procedures. In total, 42 consecutive patients undergoing LBBAp using SDES leads and newly designed delivery sheaths (LBBAp group) were compared with those treated with conventional right ventricular pacing (RVp) for atrioventricular block (RVp group, n = 84) using propensity score matching (1:2 ratio). The LBBAp was successful in 83% (35/42) of patients, with satisfactory pacing thresholds (0.8 ± 0.2 V at 0.4 ms). In the LBBAp group, the mean paced-QRS duration obtained during RV apical pacing (173 ± 18 ms) was significantly reduced by LBBAp (116 ± 14 ms, p < 0.001). Compared with the RVp group, the LBBAp group showed more physiological pacing, suggested by a much narrower paced-QRS duration (116 ± 14 vs. 151 ± 21 ms, p < 0.001). The pacing threshold was comparable in both groups. The LBBAp group revealed stable pacing thresholds for 6.8 ± 4.8 months post-implant and no serious complications including lead dislodgement or septal perforation. The novel approach of LBBAp using SDES leads and the new dedicated pre-shaped delivery sheaths was effectively and safely performed, even by inexperienced operators with LBBAp procedures. Full article

(This article belongs to the Special Issue New Insights and Future Directions in Cardiac Electrophysiology Techniques)

► Show Figures

Figure 1

12 pages, 2914 KiB

Open AccessArticle

Combination of High-Density and Coherent Mapping for Ablation of Ventricular Arrhythmia in Patients with Structural Heart Disease

by Vanessa Sciacca, Thomas Fink, Leonard Bergau, Guram Imnadze, Mustapha El Hamriti, Denise Guckel, Martin Braun, Moneeb Khalaph, Philipp Sommer and Christian Sohns

J. Clin. Med. 2022, 11(9), 2418; https://doi.org/10.3390/jcm11092418 - 26 Apr 2022

Cited by 1 | Viewed by 1600

Abstract

The present study describes our experience with a new mapping approach for ventricular arrhythmia (VA) ablation in patients with structural heart disease (SHD). Consecutive patients undergoing catheter ablation for recurrent VA were analyzed. High-density mapping was conducted in all patients. In patients with inducible VA, local activation time (LAT) mapping and a novel vector-based mapping algorithm were implemented to analyze arrhythmia propagation. In case of focal tachycardia, the location of earliest activation was targeted. In VAs with re-entrant mechanisms, zones of slow conduction based on coherent mapping were ablated. Substrate modification was performed when pathologic electrograms were identified. Seventy-four patients were included. Sixty-five patients (87.8%) were male. Ischemic cardiomyopathy was the underlying disease in 35 patients (47.3%) and nonischemic cardiomyopathy was the underlying disease in 39 patients (52.7%). Mean left ventricular ejection fraction was 33.8 ± 9.9%. Non-inducibility of any VA was achieved in 70 patients (94.6%). Termination of VA was achieved in 93.5% of patients with stable VA. In 4 patients (5.4%), partial success was achieved. VA (p < 0.001), ATP (p < 0.001) and shock burden (p = 0.001) were significantly reduced after ablation. Mean arrhythmia-free survival after 12 months was 85.1 ± 4.7%. High-density mapping in combination with coherent mapping may facilitate the understanding of the tachycardia mechanism, providing targets for effective ablation. Full article

(This article belongs to the Special Issue New Insights and Future Directions in Cardiac Electrophysiology Techniques)

► Show Figures

Figure 1

11 pages, 1509 KiB

Open AccessArticle

The BIOMONITOR III Injectable Cardiac Monitor: Clinical Experience with a Novel Injectable Cardiac Monitor

by Nico Reinsch, Anna Füting, Dennis Höwel and Kars Neven

J. Clin. Med. 2022, 11(6), 1634; https://doi.org/10.3390/jcm11061634 - 16 Mar 2022

Cited by 2 | Viewed by 3335

Abstract

Background: Injectable cardiac monitors (ICMs) are leadless subcutaneous devices for long-term monitoring of arrhythmias. The BIOTRONIK BIOMONITOR III is a novel ICM with a miniaturized profile, long sensing vector, and simplified implantation technique. Methods: R-wave amplitude was recorded immediately after implantation, the day after implantation, and after 3 months. Follow-up was scheduled after 3 months or after an event. All data from the ICM were retrieved. The anatomical position of the ICM was determined post-implantation and after 3 months. A patient questionnaire was conducted after 3 months. Results: In 36 patients (mean age 67 ± 13 years; 40% male) an ICM was inserted. Six patients were not included in the final analysis. The median time from skin cut to wound closure was 6 [IQR 5–7] minutes. Mean R-wave amplitude increased over time (0.73 ± 32 mV vs. 0.78 ± 0.38 mV vs. 0.81 ± 0.39 mV; p = ns). Three months after implantation, the ICM was in an anatomically stable position. In 14 (47%) patients, true episodes were detected. False arrhythmia alerts were detected in 13 (43%) patients. The total number of false detections was low, and the patient satisfaction rate was high. Conclusion: Implantation of the novel BIOMONITOR III is fast and uncomplicated; its sensing characteristics are excellent and improve over time, and patient satisfaction is high. Full article

(This article belongs to the Special Issue New Insights and Future Directions in Cardiac Electrophysiology Techniques)

► Show Figures

Figure 1

11 pages, 1811 KiB

Open AccessArticle

Optimal Ablation Settings Predicting Durable Scar Detected Using LGE-MRI after Modified Left Atrial Anterior Line Ablation

by Mathias Forkmann, Christian Mahnkopf, Marcel Mitlacher, Marc Wolff, Beatriz Tose Costa Paiva and Sonia Busch

J. Clin. Med. 2022, 11(3), 830; https://doi.org/10.3390/jcm11030830 - 4 Feb 2022

Viewed by 1624

Abstract

(1) Background: The modified anterior line (MAL) has been described as an alternative to the mitral isthmus line. Despite better ablation results, achieving a bidirectional line block can be challenging. We aimed to investigate the ablation parameters that determine a persistent scar on late-gadolinium enhancement magnet resonance imaging (LGE-MRI) as a surrogate parameter for successful ablation 3 months after MAL ablation. (2) Methods: Twenty-four consecutive patients who underwent a MAL ablation have been included. The indication for MAL was perimitral flutter (n = 5) or substrate ablation in the diffuse anterior left atrial (LA) low-voltage area in persistent atrial fibrillation (AF) (n = 19). The MAL was divided into three segments: segment 1 (S1) from mitral annulus to height of lower region of left atrial appendage (LAA) antrum; segment 2 (S2) height of lower region of LAA antrum to end of upper LAA antrum; segment 3 (S3) from end of upper LAA antrum to left superior pulmonary vein. Ablation was performed using a contact force irrigated catheter with a power of 40 Watt and guided by automated lesion tagging and the Ablation Index (AI). The AI target was left to the operator’s choice. An inter-lesion distance of ≤6 mm was recommended. The bidirectional block was systematically evaluated using stimulation maneuvers at the end of procedure. All patients underwent LGE-MRI imaging at 3 months, regardless of symptoms, to identify myocardial lesions (scars). (3) Results: Bidirectional MAL block was achieved in all patients. LGE-MRI imaging revealed scarring in 45 of 72 (63%) segments. In all three segments of MAL, ablation time and AI were significantly higher in scarred areas compared with non-scar areas. The mean AI value to detect a durable scar was 514.2 in S1, 486.7 in S2 and 485.9 in S3. The mean ablation time to detect a scar was 20.4 s in S1, 22.1 s in S2 and 20.2 s in S3. Mean contact force and impedance drop were not significantly different between scar and non-scar areas. (4) Conclusions: Targeting optimal AI values is crucial to determine persistent left atrial scars on an LGE-MRI scan 3 months after ablation. AI guided linear left atrial ablation seems to be effective in producing durable lesions. Full article

(This article belongs to the Special Issue New Insights and Future Directions in Cardiac Electrophysiology Techniques)

► Show Figures

Figure 1

8 pages, 2257 KiB

Open AccessArticle

Atrioventricular Nodal Reentrant Tachycardia Ablation Using Mini-Electrode Recordings

by Nicolas Clementy, Gérôme Pineaud, Arnaud Bisson and Dominique Babuty

J. Clin. Med. 2022, 11(1), 282; https://doi.org/10.3390/jcm11010282 - 5 Jan 2022

Cited by 1 | Viewed by 2923

Abstract

Catheter ablation of the slow pathway in patients with atrioventricular nodal reentrant tachycardia (AVNRT) is mainly performed using anatomical landmarks. We sought to see whether a new ablation catheter equipped with mini-electrodes may facilitate the mapping of slow pathway potentials for AVNRT ablation. We prospectively included patients referred for AVNRT in our center. Mapping and ablation were performed using an irrigated catheter equipped with 3 insulated mini-electrodes on the distal tip. Thirteen consecutive patients were included (85% female, median age 46 years). Slow pathway potentials could be identified in 77% of cases on mini-electrode bipolar tracings, versus 15% on conventional bipolar tracings (p = 0.0009). At the end of the procedure, double potentials on the ablation line were identified in all patients, only on mini-electrode bipolar tracings. Following ablation, an interval separating double potentials in sinus rhythm ≥15% of baseline tachycardia cycle length was associated with non-inducibility in all patients (p < 0.0001). No recurrence occurred during 1 year of follow-up. The use of mini-electrodes may help target slow pathway potentials during AVNRT ablation. Identification of sufficiently split double potentials on the ablation line might represent an electrophysiological endpoint in these patients. Full article

(This article belongs to the Special Issue New Insights and Future Directions in Cardiac Electrophysiology Techniques)

► Show Figures

Figure 1

14 pages, 1482 KiB

Open AccessArticle

Cardiac MRI Based Left Ventricular Global Function Index: Association with Disease Severity in Patients with ICD for Secondary Prevention

by Andreas Leonhard Schober, Carsten Jungbauer, Florian Poschenrieder, Alexander Daniel Schober, Ute Hubauer, Andreas Keyser, Sabine Fredersdorf-Hahn, Kurt Debl, Lars S. Maier, Samuel Sossalla, Stefan Buchner and Ekrem Üçer

J. Clin. Med. 2021, 10(21), 4980; https://doi.org/10.3390/jcm10214980 - 27 Oct 2021

Cited by 4 | Viewed by 1542

Abstract

Left ventricular (LV) ejection fraction (LVEF) is the most widely used prognostic marker in cardiovascular diseases. LV global function index (LVGFI) is a novel marker which incorporates the total LV structure in the assessment of LV cardiac performance. We evaluated the prognostic significance of LVGFI, measured by cardiovascular magnetic resonance (CMR), in predicting mortality and ICD therapies in a real-world (ICD) population with secondary ICD prevention indication, to detect a high-risk group among these patients. In total, 105 patients with cardiac MRI prior to the ICD implantation were included (mean age 56 ± 16 years old; 76% male). Using the MRI data for each patient LVGFI was determined and a cut-off for the LVGFI value was calculated. Patients were followed up every four to six months in our or clinics in proximity. Data on the occurrence of heart failure symptoms and or mortality, as well as device therapies and other vital parameters, were collected. Follow up duration was 37 months in median. The mean LVGFI was 24.5%, the cut off value for LVGFI 13.5%. According to the LVGFI Index patient were divided into 2 groups, 86 patients in the group with the higher LVGFI und 19 patients in the lower group. The LVGFI correlates significantly with the LVEF (r = 0.642, p < 0.001). In Kaplan–Meier analysis, a lower LVGFI (<13.5%) was associated with a higher rate of mortality and rehospitalization (p = 0.002). In contrast, echocardiographic LVEF ≤ 33% was not associated with a higher rate of mortality or rehospitalization. Multivariate Cox-regression analysis revealed a lower LVGFI (p = 0.025, HR = 0.941; 95%-CI 0.89–0.99) and diabetes mellitus (p = 0.027, HR = 0.33; 95%-CI 0.13–0.88) as an independent predictor for mortality and rehospitalization. There was no association between the combined endpoint and the LVEF_MRT, LVEF_echo, NYHA > I, the initial device or a medication (each p = n.s.). Further, in Kaplan–Meier analysis no association was evident between the LVGFI and adequate ICD therapy (p = n.s.). In secondary prevention ICD patients reduced LVGFI was shown as an independent predictor for mortality and rehospitalization, but not for ICD therapies. We were able to identify a high-risk collective among these patients, but further investigation is needed to evaluate LVGFI compared to ejection fraction, especially in patients with an elevated risk for adverse cardiac events. Full article

(This article belongs to the Special Issue New Insights and Future Directions in Cardiac Electrophysiology Techniques)

► Show Figures

Figure 1

15 pages, 1205 KiB

Open AccessArticle

Long-Term Efficacy and Impact on Mortality of Remote Magnetic Navigation Guided Catheter Ablation of Ventricular Arrhythmias

by Denise Guckel, Sarah Niemann, Marc Ditzhaus, Stephan Molatta, Leonard Bergau, Thomas Fink, Vanessa Sciacca, Mustapha El Hamriti, Guram Imnadze, Philipp Steinhauer, Martin Braun, Moneeb Khalaph, Georg Nölker, Philipp Sommer and Christian Sohns

J. Clin. Med. 2021, 10(20), 4695; https://doi.org/10.3390/jcm10204695 - 13 Oct 2021

Cited by 7 | Viewed by 1894

Abstract

Remote magnetic navigation (RMN) facilitates ventricular arrhythmia (VA) ablation. This study aimed to evaluate the long-term efficacy of RMN-guided ablation for ventricular tachycardia (VT) and premature ventricular contractions (PVC). A total of 176 consecutive patients (mean age 53.23 ± 17.55 years, 37% female) underwent VA ablation for PVC (132 patients, 75%) or VT (44 patients, 25%). The cohort consisted of 119 patients (68%) with idiopathic VA, 31 (18%) with ischemic (ICM), and 26 (15%) with dilated cardiomyopathy (DCM). VA recurrence was observed in 69 patients (39%, mean age 51.71 ± 19.91 years, 23% female) during a follow-up period of 5.48 years (first quartile 770.50 days, second quartile 1101.50 days, third quartile 1615.50 days). Left ventricular ejection fraction <40% lead to a significantly increased risk for VA (p = 0.031*). Multivariate analyses found DCM to be an independent predictor (IP) for VA recurrence (p < 0.001*, hazard ratio (HR) 3.74, confidence interval (CI) 1.58–8.88). ICM resulted in a lower increase in VA recurrence (p = 0.221, HR 1.49, CI 0.79–2.81). Class I/III/IV antiarrhythmic drug therapy (AADs) was also identified as IP for recurrence (p = 0.030*, HR 2.48, CI 1.11–5.68). A total of 16 patients (9%) died within the observational period. RMN-guided ablation of VA lead to acceptable long-term results. An impaired LV function, DCM, and AADs were associated with a significant risk for VA recurrence. Personalized paths are needed to improve efficacy and outcome. Full article

(This article belongs to the Special Issue New Insights and Future Directions in Cardiac Electrophysiology Techniques)

► Show Figures

Figure 1

10 pages, 1210 KiB

Open AccessArticle

Left Atrial Fibrosis after Single Shot Guided Pulmonary Vein Isolation

by Shibu Mathew, Islam Saboukh, Parminder Singh, Bastian Fries, Victoria Johnson, Nikita Schneider, Christian Fraebel, Ritvan Chasan, Christian W. Hamm and Jörn Schmitt

J. Clin. Med. 2021, 10(19), 4478; https://doi.org/10.3390/jcm10194478 - 28 Sep 2021

Viewed by 1518

Abstract

Cryoballoon (CB)-based pulmonary vein isolation (PVI) is an effective treatment modality for patients with atrial fibrillation (AF) with encouraging acute and long-term outcome data. However, the size of collaterally created lesion sets adjacent to the pulmonary veins (PVs) remains unclear, especially when CB ablation is performed with individualized time-to-isolation (TTI) protocols. This study seeks to investigate the extension of lesions at the posterior wall and the roof of the left atrium (LA). Thirty patients with paroxysmal or persistent AF underwent ablation with a fourth-generation CB. The individual freeze-cycle duration was set at TTI + 120 s. A total of 120 PVs were identified, and all were successfully isolated. A three-dimensional electroanatomical high-density (HD) mapping of the LA was performed in every patient before and after PVI. The surface areas of the posterior wall and LA roof were measured and compared with lesion extension after PVI. After CB ablation, 65.6 ± 16.9% of the posterior wall and 75.4 ± 18.4% of the LA roof remained unablated. In addition, non-antral lesion formation was observed in every patient in at least one PV. After CB ablation, anterior antral parts of the superior PVs showed the greatest unablated areas compared with the other antral areas. HD re-mapping after CB-based PVI demonstrated that major regions of the posterior wall and roof remained electrically normal and unaffected. Unablated antral areas were localized predominantly in the anterior segments of the superior PVs and may be partly responsible for AF recurrence. Full article

(This article belongs to the Special Issue New Insights and Future Directions in Cardiac Electrophysiology Techniques)

► Show Figures

Figure 1

12 pages, 2568 KiB

Open AccessArticle

Echocardiographic Evaluation of LV Function in Patients with Tachyarrhythmia and Reduced Left Ventricular Function in Response to Rhythm Restoration

by Christian Schach, Thomas Körtl, Rolf Wachter, Lars S. Maier and Samuel Sossalla

J. Clin. Med. 2021, 10(16), 3706; https://doi.org/10.3390/jcm10163706 - 20 Aug 2021

Cited by 2 | Viewed by 1535

Abstract

Aims: Tachyarrhythmia due to atrial fibrillation (AF) is often associated with reduced left ventricular (LV) function and has been proposed to cause arrhythmia-induced cardiomyopathy (AIC). However, the precise diagnostics of AIC and reversibility after rhythm restoration are poorly understood. Our aim was to investigate systolic LV function in tachycardic AF and to evaluate the direct effect of rhythm restoration. Methods: We prospectively studied 24 patients (71% male, age 65 ± 9 years) with tachycardic AF and newly diagnosed reduced left ventricular ejection fraction (LVEF). Just before and immediately after electrical cardioversion (ECV), transthoracic echocardiography was performed. Geometric as well as functional data were assessed. Results: Patients presented with a heart rate (HR) of 117.4 ± 21.6/min and a 2D-/3D-LVEF of 32 ± 9/31 ± 8%. ECV to sinus rhythm normalized HR to 77 ± 11/min with an increase of 2D-/3D-LVEF to 37 ± 9/37 ± 10% (p < 0.01 vs. baseline, each). Left ventricular geometry changed with an increase of end-diastolic volume (LVEDV) while end-systolic volume (LVESV) remained unchanged. Parameters concerning myocardial deformation (global longitudinal strain (GLS), strain rate (SR)) decreased whereas the RR interval-corrected GLS (GLSc) remained unchanged. In a simple linear regression model, GLS correlated with 2D- and 3D-LVEF not only before (pre) ECV, but also after (post) ECV. We demonstrate that the increase of LVEF and GLS (ratios pre/post) correlates with the change of HR (ΔHR; R² = 0.20, 0.33 and 0.32, p < 0.05 each), whereas ratios of GLSc and SR do not significantly correlate with HR (R² = 0.03 and 0.01, p = n.s. each). Conclusion: In patients with tachyarrhythmia and reduced ejection fraction, ECV leads to immediate improvement in EF and GLS while HR-corrected LV contractility remains unchanged. This suggests that the immediate effects of rhythm restoration are mostly related to changes in left ventricular volume, but not to an acute improvement of heart-rate independent contractility. Full article

(This article belongs to the Special Issue New Insights and Future Directions in Cardiac Electrophysiology Techniques)

► Show Figures

Figure 1

Review

Jump to: Research

9 pages, 1820 KiB

Open AccessReview

Cardiac Rhythm Monitoring Using Wearables for Clinical Guidance before and after Catheter Ablation

by Henrike Aenne Katrin Hillmann, Samira Soltani, Johanna Mueller-Leisse, Stephan Hohmann and David Duncker

J. Clin. Med. 2022, 11(9), 2428; https://doi.org/10.3390/jcm11092428 - 26 Apr 2022

Cited by 12 | Viewed by 2210

Abstract

Mobile health technologies are gaining importance in clinical decision-making. With the capability to monitor the patient’s heart rhythm, they have the potential to reduce the time to confirm a diagnosis and therefore are useful in patients eligible for screening of atrial fibrillation as well as in patients with symptoms without documented symptom rhythm correlation. Such is crucial to enable an adequate arrhythmia management including the possibility of a catheter ablation. After ablation, wearables can help to search for recurrences, in symptomatic as well as in asymptomatic patients. Furthermore, those devices can be used to search for concomitant arrhythmias and have the potential to help improving the short- and long-term patient management. The type of wearable as well as the adequate technology has to be chosen carefully for every situation and every individual patient, keeping different aspects in mind. This review aims to describe and to elaborate a potential workflow for the role of wearables for cardiac rhythm monitoring regarding detection and management of arrhythmias before and after cardiac electrophysiological procedures. Full article

(This article belongs to the Special Issue New Insights and Future Directions in Cardiac Electrophysiology Techniques)

► Show Figures

Journal Menu

Journal Browser

New Insights and Future Directions in Cardiac Electrophysiology Techniques

Share This Special Issue

Special Issue Editors

Special Issue Information

Keywords

Published Papers (10 papers)

Research

Review

Further Information

Guidelines

MDPI Initiatives

Follow MDPI